English
This article is from Disease Models & Mechanisms , volume 6 . Abstract Invasive fungal infections (IFIs) are a major cause of death in organ transplant patients. The murine hydrocortisone-mediated immunosuppression model of pulmonary aspergillosis is commonly used to characterise IFIs in these patients. However, this model does not take into account the effects of calcineurin inhibitors on transplant immunity to IFIs or the fungal calcineurin pathway, which is required for both virulence and antifungal drug resistance. To address these two issues, a new and clinically relevant transplant immunosuppression model of tacrolimus (FK506) and hydrocortisone-associated pulmonary aspergillosis was developed. We first characterised IFIs in 406 patients with a lung transplant. This showed that all of the patients with pulmonary aspergillosis were immunosuppressed with calcineurin inhibitors and steroids. Murine pharmacokinetic studies demonstrated that an ideal dose of 1 mg/kg/day of FK506 intraperitoneally produced blood trough levels in the human therapeutic range (5–12 ng/ml). There was increased mortality from pulmonary aspergillosis in a transplant-relevant immunosuppression model using
Sign in with your free account to read, download EPUBs or listen.
Ebook · A new and clinically relevant murine model of solid-organ transplant aspergillosis. · Herbst, Susanne, Shah, Anand, Carby, Martin, Chusney, Gary, Kikkeri, Naresh, Dorling, Anthony, Bignell, Elaine, Shaunak, Sunil · Internet Archive